🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 16 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/01/2023 | 65,32 | 66,54 | 64,75 | 66,19 | +0,79% | 2,74% | 112.500 |
| 04/01/2023 | 66,72 | 67,79 | 65,40 | 65,67 | -0,55% | 3,58% | 141.300 |
| 03/01/2023 | 67,56 | 68,42 | 65,86 | 66,03 | -1,15% | 3,79% | 95.000 |
| 30/12/2022 | 66,86 | 67,43 | 65,57 | 66,80 | -1,17% | 2,78% | 111.900 |
| 29/12/2022 | 67,20 | 69,54 | 66,76 | 67,59 | +1,96% | 4,14% | 155.700 |
| 28/12/2022 | 65,55 | 66,72 | 64,84 | 66,29 | +1,28% | 2,87% | 102.700 |
| 27/12/2022 | 67,77 | 67,77 | 65,20 | 65,45 | -2,78% | 3,79% | 85.500 |
| 23/12/2022 | 67,81 | 68,31 | 66,14 | 67,32 | +0,43% | 3,20% | 113.600 |
| 22/12/2022 | 64,85 | 67,10 | 63,53 | 67,03 | +2,70% | 5,51% | 200.200 |
| 21/12/2022 | 63,51 | 67,13 | 63,51 | 65,27 | +3,55% | 5,70% | 274.600 |
| 20/12/2022 | 65,00 | 65,77 | 62,10 | 63,03 | -3,15% | 5,65% | 262.500 |
| 19/12/2022 | 63,51 | 66,72 | 62,93 | 65,08 | +3,88% | 5,97% | 396.900 |
| 16/12/2022 | 61,34 | 63,59 | 60,93 | 62,65 | +0,80% | 4,34% | 1.369.300 |
| 15/12/2022 | 63,77 | 64,68 | 61,68 | 62,15 | -3,03% | 4,70% | 397.900 |
| 14/12/2022 | 63,74 | 64,76 | 62,58 | 64,09 | +0,74% | 3,42% | 339.500 |
| 13/12/2022 | 66,76 | 68,22 | 62,78 | 63,62 | -1,82% | 8,15% | 318.200 |
| 12/12/2022 | 63,12 | 65,94 | 62,34 | 64,80 | +2,18% | 5,70% | 298.700 |
| 09/12/2022 | 64,20 | 64,96 | 62,90 | 63,42 | -1,38% | 3,21% | 177.800 |
| 08/12/2022 | 66,18 | 66,51 | 63,60 | 64,31 | -2,15% | 4,40% | 171.200 |
| 07/12/2022 | 67,95 | 68,46 | 65,45 | 65,72 | -3,11% | 4,43% | 143.400 |
| 06/12/2022 | 69,91 | 69,91 | 67,18 | 67,83 | -2,68% | 3,91% | 172.400 |
| 05/12/2022 | 72,35 | 73,07 | 68,66 | 69,70 | -4,07% | 6,10% | 193.900 |
| 02/12/2022 | 69,12 | 73,09 | 68,44 | 72,66 | +3,81% | 6,73% | 194.700 |
| 01/12/2022 | 72,90 | 72,90 | 69,66 | 69,99 | -3,99% | 4,44% | 158.100 |
| 30/11/2022 | 71,86 | 73,51 | 70,34 | 72,90 | +2,00% | 4,41% | 211.200 |
| 29/11/2022 | 71,49 | 73,50 | 70,50 | 71,47 | -0,25% | 4,20% | 179.100 |
| 28/11/2022 | 73,22 | 74,66 | 71,16 | 71,65 | -2,66% | 4,78% | 183.500 |
| 25/11/2022 | 73,00 | 74,51 | 72,86 | 73,61 | +0,64% | 2,26% | 48.100 |
| 23/11/2022 | 74,56 | 76,00 | 73,06 | 73,14 | -2,31% | 3,94% | 145.000 |
| 22/11/2022 | 78,28 | 78,55 | 74,13 | 74,87 | -4,62% | 5,65% | 187.700 |